BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 8649359)

  • 1. Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells.
    Liu PC; Phillips MA; Matsumura F
    Mol Pharmacol; 1996 Jun; 49(6):989-97. PubMed ID: 8649359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAAT/enhancer-binding protein beta is not affected by tetrachlorodibenzo-p-dioxin (TCDD) inhibition of 3T3-L1 preadipocyte differentiation.
    Chen CL; Brodie AE; Hu CY
    Obes Res; 1997 Mar; 5(2):146-52. PubMed ID: 9112250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) with induced adipocyte differentiation in mouse embryonic fibroblasts (MEFs) involves tyrosine kinase c-Src.
    Vogel CF; Matsumura F
    Biochem Pharmacol; 2003 Oct; 66(7):1231-44. PubMed ID: 14505802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta.
    Clarkson RW; Chen CM; Harrison S; Wells C; Muscat GE; Waters MJ
    Mol Endocrinol; 1995 Jan; 9(1):108-20. PubMed ID: 7760844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of C/EBPalpha and induction of C/EBPbeta by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse adipose tissue and liver.
    Liu PC; Dunlap DY; Matsumura F
    Biochem Pharmacol; 1998 May; 55(10):1647-55. PubMed ID: 9634001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin suppresses TCDD-induced wasting syndrome in a cultured adipocyte model.
    Ashida H; Harada K; Mishima S; Mitani T; Yamashita Y; Matsumura F
    Pestic Biochem Physiol; 2015 May; 120():14-20. PubMed ID: 25987215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
    Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
    Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of adipocyte differentiation by CCAAT/enhancer binding protein alpha (C/EBP alpha).
    Lane MD; Lin FT; MacDougald OA; Vasseur-Cognet M
    Int J Obes Relat Metab Disord; 1996 Mar; 20 Suppl 3():S91-6. PubMed ID: 8680485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis.
    Wu Z; Xie Y; Bucher NL; Farmer SR
    Genes Dev; 1995 Oct; 9(19):2350-63. PubMed ID: 7557387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells.
    Moreno-Aliaga MJ; Matsumura F
    Mol Pharmacol; 1999 Jul; 56(1):91-101. PubMed ID: 10385688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the high expression of C/EBPbeta protein in F442A cells and their relative resistance to antiadipogenic action of TCDD in comparison to 3T3-L1 cells.
    Liu PC; Moreno-Aliaga MJ; Dunlap DY; Hu XM; Denison MS; Matsumura F
    J Biochem Mol Toxicol; 2002; 16(2):70-83. PubMed ID: 11979424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on adipogenic differentiation and insulin-induced glucose uptake in 3T3-L1 cells.
    Hsu HF; Tsou TC; Chao HR; Kuo YT; Tsai FY; Yeh SC
    J Hazard Mater; 2010 Oct; 182(1-3):649-55. PubMed ID: 20633992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane (p,p'-DDT) on 3T3-L1 and 3T3-F442A adipocyte differentiation.
    Moreno-Aliaga MJ; Matsumura F
    Biochem Pharmacol; 2002 Mar; 63(5):997-1007. PubMed ID: 11911853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
    Cao Z; Umek RM; McKnight SL
    Genes Dev; 1991 Sep; 5(9):1538-52. PubMed ID: 1840554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apigenin isolated from Daphne genkwa Siebold et Zucc. inhibits 3T3-L1 preadipocyte differentiation through a modulation of mitotic clonal expansion.
    Kim MA; Kang K; Lee HJ; Kim M; Kim CY; Nho CW
    Life Sci; 2014 Apr; 101(1-2):64-72. PubMed ID: 24582594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of CCAAT/enhancer binding protein alpha (C/EBP alpha) gene expression by thiazolidinediones in 3T3-L1 adipocytes.
    Hemati N; Erickson RL; Ross SE; Liu R; MacDougald OA
    Biochem Biophys Res Commun; 1998 Mar; 244(1):20-5. PubMed ID: 9514873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program.
    Lin FT; Lane MD
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8757-61. PubMed ID: 8090719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of preadipocyte differentiation induce COUP-TF binding to a PPAR/RXR binding sequence.
    Brodie AE; Manning VA; Hu CY
    Biochem Biophys Res Commun; 1996 Nov; 228(3):655-61. PubMed ID: 8941335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of CCAAT/enhancer binding protein isoforms by serum and glucocorticoids in the rat intestinal epithelial crypt cell line IEC-6.
    Boudreau F; Blais S; Asselin C
    Exp Cell Res; 1996 Jan; 222(1):1-9. PubMed ID: 8549649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.